Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Resectable MMR-deficient Solid Tumors
×
30 days
×
Clear all
Filters
2
NCT06279130
2026-03-05
NEOASIS
The Netherlands Cancer Institute
Phase 2/3
Recruiting
133 enrolled